Logo

Graduate School of Biomedical Sciences
Alumni Association

Gregory J. Tsongalis, Ph.D.
2007

Gregory Tsongalis earned a Doctor of Philosophy degree in 1990 in the Department of Pathology under the guidance of Dr. W. Clark Lambert.  His doctoral dissertation was on DNA repair mechanisms in the genetic diseases, xeroderm pigmentosum and Fanconi anemia.  After completing his postdoctoral training in Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill, Dr. Tsongalis joined the Clinical Chemistry Training Program in the Division of Molecular Pathology and Clinical Chemistry at the University of North Carolina.  While there, he developed assays for in situ amplification and diagnostic testing for fragile X syndrome as well as maintaining his interest in human cancers.

Dr. Tsongalis is one of the leaders in the emerging field of molecular diagnostics.  He is certified as a high complexity clinical laboratory director and is currently the Director of Molecular Pathology and co-director of the Pharmacogenomics program at the Dartmouth-Hitchcock Medical Center in Lebanon, NH.  His area of expertise is in clinical molecular diagnostic applications for genetic, hematologic, infectious, and neoplastic diseases.  His research interests are in the pathogenesis of solid tumors, disease association of SNP genotyping and personalized medicine.

Dr. Tsongalis has authored/edited five textbooks in the field of molecular pathology, published more than eighty peer reviewed manuscripts, and has been an invited speaker at both national and international meetings.  Dr. Tsongalis has been the recipient of numerous investigator/scientist awards.  He has served on numerous committees of the American Association for Clinical Chemistry, the Association for Molecular Pathology and the American Society for Investigative Pathology.  He is on the editorial review board of a number of refereed journals, as well as a member of an FDA review board and numerous corporate advisory boards.  Dr. Tsongalis is currently the President-elect of the Association for Molecular Pathology.